Xiaolan Bian
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Antibiotic Resistance in Bacteria 4
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Drug-Induced Hepatotoxicity and Protection 2
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Liang Zhang (2 shared papers)Zhitao Yang (3 shared papers)Hai‐Shu Lin (1 shared paper)Size Li (1 shared paper)Min Zhang (1 shared paper)Yujie Wang (1 shared paper)Guochao Shi (1 shared paper)Yan‐Ru Lou (1 shared paper)
- Journals
- Annals of Translational Medicine (3 papers)Frontiers in Pharmacology (3 papers)Talanta (2 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)Infectious Diseases and Therapy (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaolan Bian
36 papers receiving 413 citations
Peers
Comparison fields: 5 of 67
- Molecular Medicine 99
- Pharmacology 66
- Drug Discovery 1
- Ophthalmology 32
- Pharmacology 28
Countries citing papers authored by Xiaolan Bian
This map shows the geographic impact of Xiaolan Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Bian more than expected).
Fields of papers citing papers by Xiaolan Bian
This network shows the impact of papers produced by Xiaolan Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Bian. The network helps show where Xiaolan Bian may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolan Bian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 59 | |
| 2 | 2021 | 39 | |
| 3 | 2021 | 34 | |
| 4 | 2022 | 29 | |
| 5 | 2020 | 25 | |
| 6 | 2021 | 24 | |
| 7 | 2020 | 21 | |
| 8 | 2020 | 14 | |
| 9 | 2021 | 13 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 12 | |
| 13 | 2022 | 12 | |
| 14 | 2022 | 12 | |
| 15 | 2021 | 11 | |
| 16 | 2024 | 10 | |
| 17 | 2022 | 9 | |
| 18 | 2023 | 9 | |
| 19 | 2021 | 8 | |
| 20 | 2022 | 8 |
About Xiaolan Bian
Xiaolan Bian is a scholar working on Molecular Medicine, Pharmacology, Pathology and Forensic Medicine, Pharmacology and Nephrology, having authored 38 papers that have together received 420 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Chemotherapy-induced organ toxicity mitigation (4 papers), Antibiotic Resistance in Bacteria (4 papers), Acute Kidney Injury Research (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Glaucoma and retinal disorders (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Molecular Medicine (99 citations), Pharmacology (66 citations), Drug Discovery (1 citation), Ophthalmology (32 citations) and Pharmacology (28 citations). Xiaolan Bian has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Liang Zhang, Zhitao Yang, Hai‐Shu Lin, Size Li, Min Zhang, Yujie Wang, Guochao Shi, Yan‐Ru Lou, Yiqun Yu and Enqiang Mao. Their work appears in journals such as Annals of Translational Medicine, Frontiers in Pharmacology, Talanta, Journal of Pharmaceutical and Biomedical Analysis and Infectious Diseases and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.